Bengaluru, Karnataka – Global life sciences company Cytiva has inaugurated a new 30,000 square-foot bioprocessing centre in Bengaluru, designed to support biopharmaceutical companies with advanced process development and validation services.
The expanded centre, part of Cytiva’s Fast Trak network, consolidates upstream and downstream development, optimisation, scale-up, and validation operations under one roof. It aims to help customers shorten drug development timelines, reduce manufacturing risk, and scale biologic processes with enhanced efficiency and reliability.
Integrated Bioprocess Development Services
The facility provides comprehensive services including process optimisation, bioreactor scale-up support (single-use to 200 L), and ISO-certified validation labs for specialised testing. Its design enables production of toxicity batch materials for preclinical work, training programmes, and regulatory-compliant documentation — making it a pivotal hub for early-stage biopharma research.
According to Cytiva’s leadership team, the Bengaluru centre reinforces India’s scientific capabilities in the global biologics and biosimilars landscape. The facility supports modalities such as monoclonal antibodies, recombinant proteins, mRNA & plasmid DNA products, and viral vectors — serving both domestic and Asia-Pacific biopharma customers.
Impact on India’s Bioeconomy & Biopharma Growth
India’s biotechnology sector continues to expand rapidly, with the government and industry stakeholders targeting significant growth in the national bioeconomy by 2030. The addition of Cytiva’s centre aligns with this trajectory by bolstering local infrastructure for drug research, enhancing R&D capabilities, and reducing dependence on foreign contract development organisations.
The facility’s advanced process development platforms and training support are expected to strengthen India’s position as a biopharma ecosystem hub, offering quicker development cycles and regulatory readiness for new biologic therapies. This growth in the life sciences sector also complements the rising demand for high-quality commercial and industrial infrastructure in the region.
Also Read: Brigade Enterprises Secures Environmental Clearance for New Residential Landmark in Mysuru
Alkka Roy writes about real estate trends, property insights, and investment opportunities, helping readers make informed decisions in a dynamic market.
Related news
